Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

41.26
Delayed Data
As of May 27
 +0.15 / +0.36%
Today’s Change
37.63
Today|||52-Week Range
54.98
-3.26%
Year-to-Date
Medivation Fires Back Following Sanofi's Board Proposal
May 27 / TheStreet.com - Paid Partner Content
5 Things You Need to Know About Zika Virus
May 26 / MotleyFool.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content
Novo Nordisk IDegLira Recommended by FDA Advisory Committee
May 25 / Zacks.com - Paid Partner Content
Relypsa Scores Big Win When Pharma Rival Flops at FDA
May 27 / TheStreet.com - Paid Partner Content
European Markets End in Positive Territory; Rally for Second Day
May 25 / TheStreet.com - Paid Partner Content
Seattle Genetics Starts Trial on Acute Myeloid Leukemia Drug
May 26 / Zacks.com - Paid Partner Content
Sanofi Moves to Oust Medivation Board
May 25 / TheStreet.com - Paid Partner Content
Sanofi's Diabetes Drug Combination Wins FDA Panel Backing
May 26 / Zacks.com - Paid Partner Content
Lilly's (LLY) R&D Update, Targets 20 New Launches by 2023
May 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.11
Today’s open40.97
Day’s range40.85 - 41.26
Volume883,625
Average volume (3 months)1,974,448
Market cap$104.7B
Dividend yield3.95%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.70%
Revenue growth (last year)-14.57%
P/E ratio24.7
Price/Sales2.96
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.34-0.79%
NVONovo Nordisk-0.61-1.09%
ABBVAbbVie+0.81+1.31%
AGNAllergan+3.58+1.54%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)$0.73
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts

Partner Offers

Search for Jobs